InVivo is a Massachusetts-based biotechnology company that develops neurological products for the treatment of spinal cord injuries.
Business Model:
Revenue: $698M
Employees: 2-10
Address: One Kendall Square
City: Cambridge
State: MA
Zip: 02139
Country: US
InVivo is a Massachusetts-based biotechnology company that develops neurological products for the treatment of spinal cord injuries.
Contact Phone:
+16178635500
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/5/2010
Ticker Symbol:
NVIV
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2018 | Post-IPO Equity | 1 | $15.2M |
Lincoln Park Capital Fund Lincoln Park Capital Fund Lincoln Park Capital Fund Lincoln Park Capital Fund |
4/2020 | Private Placement | $3M | 3/2016 | Secondary Offering | $28M | 10/2022 | Private Placement | - | 10/2022 | Post-IPO Equity | $9M | 10/2010 | Unattributed | $10.5M | 11/2019 | Post-IPO Equity | $840k | 12/2010 | Post-IPO Equity | 2 | $13M |
Montrose Capital Partners Spencer Trask &a; Co Spencer Trask &a; Co Montrose Capital Partners Spencer Trask &a; Co Spencer Trask &a; Co |
4/2020 | Post-IPO Equity | $3M | 3/2016 | Post-IPO Equity | $32.2M | 10/2022 | Post-IPO Equity | $9M | 10/2011 | Post-IPO Equity | 1 | $30M |
SternAegis SternAegis |
10/2020 | Post-IPO Equity | $15M | 3/2020 | Post-IPO Equity | $7M | 10/2022 | Private Placement | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|